ArticleJournal of cancer survivorship : research and practice2026
Frailty and risk of common chronic diseases among cancer survivors: a prospective cohort study.
Article in Journal of cancer survivorship : research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeWe examined the impact of baseline frailty on the incidence of diverse chronic diseases among cancer survivors.
methodsWe analyzed 21,577 cancer survivors (aged 39-70) from the UK Biobank, excluding those with baseline diseases of interest. Baseline frailty was assessed using the frailty phenotype (range, 0-5) and the frailty index (range, 0-1). Incident cases across 39 chronic diseases were identified via hospital and death records. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% CIs.
resultsFrailty was significantly associated with an increased risk of multiple chronic diseases among cancer survivors, with the most pronounced overall effect observed for mental and neurological disorders. Overall, frailty increased the incidence of 28 out of 39 chronic diseases, encompassing all 8 cardiometabolic diseases, 5 of 10 mental/neurological diseases, 5 of 6 digestive system diseases, and 10 of 15 other conditions. Within these categories, the frailty index showed the greatest impact on heart failure (HR, 1.48 [1.36-1.61]); depression (HR, 2.39 [2.19-2.62]); irritable bowel syndrome (HR, 1.79 [1.54-2.08]); and bronchiectasis (HR, 2.11 [1.84-2.41]). Stratified analyses revealed that the association between frailty and risk of anxiety and depression was stronger in cancer survivors aged < 60 years, while prostate cancer survivors exhibited a significantly higher risk for bronchiectasis and diverticular disease. Sensitivity analyses confirmed the stability of the results.
conclusionFrailty was prospectively associated with an increased risk of diverse chronic diseases in cancer survivors. IMPLICATIONS FOR CANCER SURVIVORS: Routine assessment of frailty may help identify survivors who need targeted interventions and proactive clinical monitoring to prevent long-term comorbidities and enhance quality of life.
Indexed as
Identifiers
42850428What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.